Abstract Introduction: The American Thyroid Association appointed a Task Force of experts
to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the …

Bone represents the second most common site of distant metastases in differentiated thyroid
cancer (DTC). The clinical course of DTC patients with bone metastases (BM) is quite …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

An ever-increasing population of patients with papillary thyroid cancer is engaging with
health care systems around the world. Numerous questions about optimal management …

Until recently, no truly effective treatment options have existed for patients with radioactive
iodine (RAI)-refractory differentiated thyroid cancer (DTC), a serious disease with poor …

Purpose Bone metastases (BM) from differentiated thyroid carcinoma (DTC) impact
negatively the quality of life and the life expectancy of patients. The aim of the study was (a) …

Radioiodine (RAI) refractory differentiated thyroid cancer is an uncommon and challenging
situation that requires a multidisciplinary approach to therapeutic strategies. The definition of …

Simple Summary Patients with bone metastases (BMs) from differentiated thyroid carcinoma
(DTC) can live longer than those with BMs from other cancers. BMs from DTC create …

Patients with thyroid cancer (TC) usually have an excellent prognosis; however, 5–10% of
them develop an advanced disease. The prognosis of this subgroup is still favourable if the …